| Name | Title | Contact Details |
|---|
Established in 1988, Health Design Plus (HDP) initially a Care Management company, expanded its suite of services to include network development/management and claims administration. With over 25 years of continued success, Health Design Plus continues to offer new products, such as Good Health by Design®, a suite of Wellness programs including LifeStart®, a Maternity Management program, Wellness Counts®, a biometric screening and coaching program, Carewise®, a Care Management program, and Healthy Living™, a Disease Management program, designed to fit all wellness-readiness levels, promoting healthier lifestyle choices and behavior modification to reach personal goals. Health Design Plus helps clients fuel their fiscal health in the marketplace while improving the health of their employees and members. Recently, HDP has gained national recognition as the industry leader in Domestic Travel Surgery programs with the launch of CliniFIT™ Centers of Excellence. HDP`s CliniFIT™ Centers of Excellence programs offer employers unparalleled commitment to consistently deliver safe, effective, evidence-based care. Qualified employees have access to recognized leaders in specific fields of medicine, Cardiac, Spine and Joint Replacement.
Arizona Spinal Cord Injury Association is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cary Medical Center is a 65-bed acute care hospital in Caribou, Maine. Well known for its patient-centered services, the hospital and its staff have won numerous state and national awards for quality in both customer service and clinical performance. The Cary family includes approximately 540 employees, more than 60 active medical staff providers, 100 courtesy and consulting physicians, and 75 volunteers. In collaboration with Pines Health Services, a Federally Qualified Health Center, Cary Medical Center services include: general surgery, pediatrics, 24-hour emergency medicine, obstetrics and gynecology, orthopedics, physical and occupational therapy, one day surgery, family practice, sports medicine, cardiac and pulmonary rehabilitation, internal medicine, urology, radiology, pathology, and a wide variety of specialty clinics. The collaborative relationship that has developed between Cary and Pines has been called a model for the nation. The hospital has made major investments in technology and was one of the first rural hospitals in the nation to develop bed-side medication barcoding, closed loop medication dispensing, and the hospital was a key player in the development of HealthInfoNet (a statewide health information system). The hospital also has available the latest diagnostic technology including multi-slice CT Scan, MRI, Nuclear Medicine, Advanced Ultra-Sound, Stereo Tactic Biopsy, and highly automated Medical Laboratory. Cary Medical Center has all private patient rooms and completed a million dollar renovation to its acute care unit in 2017. Thanks to nearly $1 million dollars raised by our generous communities, the hospital opened the Women`s Imaging Center (2014) and Jefferson Cary Cancer Center (2015) to provide comprehensive cancer care and screening options closer to home. Cary Medical Center has also developed a unique and powerful relationship with Aroostook County Veterans, the Maine VA Health System and Maine Veterans Homes. Cary was the first hospital in the nation to establish a Veterans Administration Outpatient Clinic located in a private rural hospital. Additionally, on the hospital`s campus is a 40-bed long-term care facility and a 30-bed residential care facility operated by the Maine Veterans Home.
Lincoln County Ambulance District is a Troy, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.